NO20064337L - Farmasoytisk middel inneholdende hyaluronan som en aktiv ingrediens - Google Patents

Farmasoytisk middel inneholdende hyaluronan som en aktiv ingrediens

Info

Publication number: NO20064337L
Authority: NO; Norway
Prior art keywords: active ingredient; agent containing; pharmaceutical agent; containing hyaluronan; hyaluronan
Prior art date: 2005-09-26

Application number

NO20064337A

Other languages

English (en)

Norwegian (no)

Inventor

Hiroko Yamanokuchi

Tadahiko Kato

Akira Asari

Original Assignee

Glycoscience Lab Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-09-26

Filing date

2006-09-25

Publication date

2007-03-27

2005-09-26 Priority claimed from JP2005277918A external-priority patent/JP2007084509A/ja

2005-10-12 Priority claimed from JP2005297991A external-priority patent/JP2007106688A/ja

2005-12-01 Priority claimed from JP2005348017A external-priority patent/JP2007153761A/ja

2006-09-25 Application filed by Glycoscience Lab Inc filed Critical Glycoscience Lab Inc

2007-03-27 Publication of NO20064337L publication Critical patent/NO20064337L/no

Links

KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 title abstract 3
229940099552 hyaluronan Drugs 0.000 title abstract 3
229920002674 hyaluronan Polymers 0.000 title abstract 3
239000004480 active ingredient Substances 0.000 title abstract 2
239000008177 pharmaceutical agent Substances 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
150000004044 tetrasaccharides Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Transplantation (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Dermatology (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)

NO20064337A 2005-09-26 2006-09-25 Farmasoytisk middel inneholdende hyaluronan som en aktiv ingrediens NO20064337L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2005277918A JP2007084509A (ja)	2005-09-26	2005-09-26	細胞賦活剤
JP2005297991A JP2007106688A (ja)	2005-10-12	2005-10-12	サイトカイン関連遺伝子及びケモカイン関連遺伝子の発現抑制剤
JP2005348017A JP2007153761A (ja)	2005-12-01	2005-12-01	シナプス伝達促進剤及びシナプス保護剤

Publications (1)

Publication Number	Publication Date
NO20064337L true NO20064337L (no)	2007-03-27

Family

ID=37667620

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20064337A NO20064337L (no)	2005-09-26	2006-09-25	Farmasoytisk middel inneholdende hyaluronan som en aktiv ingrediens

Country Status (7)

Country	Link
EP (1)	EP1767211B1 (de)
AR (1)	AR056091A1 (de)
AT (1)	ATE552005T1 (de)
BR (1)	BRMU8603015U (de)
CA (1)	CA2560844C (de)
NO (1)	NO20064337L (de)
RU (1)	RU2342148C2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1994934A4 (de)	2006-12-05	2010-03-10	Glycoscience Lab Inc	Therapeutisches mittel gegen degenerative arthritis
JP5117110B2 (ja) *	2007-05-28	2013-01-09	生化学工業株式会社	Ｉ型アレルギー疾患治療剤
EP2818172A4 (de) *	2012-02-22	2016-02-17	Hyaluronan Res Inst Inc	Tlr4-mittel, gewebehomöostatikum, hepatozytenwachstumsfaktorinduktor, gewebereparierendes mittel und sirtuininduktor mit hyaluronsäurefragmenten als wirkstoffe davon
IT201600079773A1 (it) *	2016-07-29	2018-01-29	Matteo Bevilacqua	Composizioni contenenti oligosaccaridi di acido ialuronico (HA4), condroitin solfato (CS2-4) ed eparan solfato (HS2-4), triterpeni pentaciclici e derivati per uso medico curativo e metodo per la preparazione di tali composizioni.
EP4085905B1 (de) *	2021-05-07	2024-02-21	TRB Chemedica AG	Hyaluronsäure zur verwendung bei der vorbeugung oder behandlung neurologischer dysfunktionen von nerven oder nervenzellen

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0852501B1 (de) *	1995-09-28	2004-12-01	Sangstat Medical Corporation	Verwendung von hyaluronsäure als immunsuppessor
JP4195107B2 (ja) *	1996-02-16	2008-12-10	生化学工業株式会社	ストレス蛋白質発現増強剤
IT1309588B1 (it) *	1999-03-05	2002-01-24	Altergon Sa	Cerotto con spessore sottile contenente betametasone ed acidoialuronico per il trattamento di psoriasi, dermatite, dermatosi.
JP2003089647A (ja) *	1999-03-10	2003-03-28	Takada Seiyaku Kk	関節性疾患治療剤
DE60140941D1 (de) *	2000-07-07	2010-02-11	Seikagaku Kogyo Co Ltd	Hyaluronsäure oligosaccharid fraktionen und medikamente, die diese enthalten
US6537968B1 (en) *	2000-07-24	2003-03-25	Alphamed Pharmaceuticals Corp	Treatment of lupus erythematosus
DE60230388D1 (de) *	2001-03-15	2009-01-29	Seikagaku Kogyo Co Ltd	Mittel zur steurung der expression von il-12
US7060691B2 (en) *	2002-10-10	2006-06-13	Giuseppe Petrigni	Pharmaceutical colloidal preparation useful in the treatment of respiratory diseases
US7511026B2 (en) *	2003-03-25	2009-03-31	Seikagaku Corporation	Therapeutic agent for nerve damage
HUP0303779A2 (en) *	2003-11-20	2006-02-28	Richter Gedeon Vegyeszet	Pharmaceutical compositions containing hyaluronan complex for the treatment of sclerosis multiplex
DE102004002001A1 (de) *	2004-01-14	2005-08-11	Reinmüller, Johannes, Dr.med.	Mittel zur Behandlung von entzündlichen Erkrankungen

2006
- 2006-09-25 NO NO20064337A patent/NO20064337L/no not_active Application Discontinuation
- 2006-09-25 CA CA2560844A patent/CA2560844C/en not_active Expired - Fee Related
- 2006-09-25 RU RU2006134169/15A patent/RU2342148C2/ru not_active IP Right Cessation
- 2006-09-26 BR BRMU8603015-9U patent/BRMU8603015U/pt not_active Application Discontinuation
- 2006-09-26 AR ARP060104194A patent/AR056091A1/es not_active Application Discontinuation
- 2006-09-26 EP EP06020126A patent/EP1767211B1/de not_active Not-in-force
- 2006-09-26 AT AT06020126T patent/ATE552005T1/de active

Also Published As

Publication number	Publication date
RU2342148C2 (ru)	2008-12-27
CA2560844C (en)	2011-05-17
RU2006134169A (ru)	2008-03-27
EP1767211A1 (de)	2007-03-28
BRMU8603015U (pt)	2007-12-11
EP1767211B1 (de)	2012-04-04
ATE552005T1 (de)	2012-04-15
AR056091A1 (es)	2007-09-19
CA2560844A1 (en)	2007-03-26

Similar Documents

Publication	Publication Date	Title
MXPA06000013A (es)	2006-03-21	Agente terapeutico para sarcoma de tejido suave.
NO20080865L (no)	2008-04-18	Spirokromanonderivater som acetyl-koenzym-A-karboksylase(ACC)inhibitorer
NO20091700L (no)	2009-06-16	Florizinanaloger som inhibitorer av glukose-ko-transporter 2
NO20075669L (no)	2008-01-04	Middel for a behandle ufrivillig bevegelse
NO20073664L (no)	2007-09-28	Peptider med neuropeptid-2-reseptor (Y2R) agonist aktivitet
EA200970081A1 (ru)	2009-06-30	Соединения, обладающие потенциирующим действием в отношении активности этионамида, и их применения
NO20090295L (no)	2009-01-20	Substituerte heteroarylderivater
NO20090175L (no)	2009-03-11	Stabile laquinimod sammensetninger
NO20074872L (no)	2007-10-30	Pyrazoler
DK1694318T3 (da)	2007-06-25	(S)-2-N-propylamino-5-hydroxytetralin som D3-agonistisk terapeutikum
NO20081160L (no)	2008-05-29	Benzimidazoltiofen forbindelser
NO20091395L (no)	2009-04-06	Nye tiofenderivater
NO20076252L (no)	2008-02-05	Oftalmiske anordninger for vedvarende levering av aktive forbindelser
ECSP088854A (es)	2008-11-27	Moduladores bencimidazolicos de vr1
NO20082793L (no)	2008-06-20	Nye tiofenderivater
NO20064041L (no)	2006-09-08	Substituerte pyrazolin sammensetninger, deres fremstilling og anvendelse som medikamenter
NO20083863L (no)	2008-12-03	Pyrazoler som 11-beta-hsd-1
ATE530524T1 (de)	2011-11-15	Substituierte sulfonamid-derivate
NO341679B1 (no)	2017-12-18	Substituerte pyridylamidforbindelser, fremstilling av slike og farmasøytiske sammensetninger inneholdende slike, samt anvendelse som modulatorer av histamin H3-reseptoren
NO20082445L (no)	2008-09-03	Neuropeptid-2 reseptor-agonister
NO20092535L (no)	2009-08-06	Fumaratsalt av (alfa S, beta R)-6-brom-alfa-[2-(dimetylamino)etyl]-2-metoksy-alfa-1-naftalenyl-beta-fenyl-3-kinolinetanol
NO20090738L (no)	2009-04-27	Tilveiebringelse av EP2 agonister, fremgangsmate for fremstilling derav, farmasoytiske sammensetninger inneholdende disse forbindelser og fremgangsmater for anvendelse av forbindelsene og sammensetningene for a senke intraokkulaert trykk og behandle glaukom
UA110207C2 (xx)	2015-12-10	ФАРМАЦЕВТИЧНА ТАБЛЕТКА, ЯКА МІСТИТЬ 1-(β-D-ГЛЮКОПІРАНОЗИЛ)-4-МЕТИЛ-3-$5-(4-ФТОРФЕНІЛ)-2-ТІЄНІЛМЕТИЛ]БЕНЗОЛ ЯК ІНГІБІТОР НАТРІЙЗАЛЕЖНОГО ПЕРЕНОСНИКА ГЛЮКОЗИ (НЗПГ)
NO20082285L (no)	2008-06-18	3-aminosyklopentankarboksamider som modulatorer av kjemokinreseptorer
NI200900052A (es)	2010-02-01	Heterocíclicos derivados de los inhibidores de metaloproteasa

Legal Events

Date	Code	Title	Description
2014-04-28	FC2A	Withdrawal, rejection or dismissal of laid open patent application